Beijing stressed that strengthening the management of paracetamol and oxycodone tablets should start from three aspects

This morning, Beijing municipal market supervision and Administration Bureau announced the notice of Beijing Municipal Drug Administration on strengthening the management of paracetamol oxycodone tablets In order to strengthen the management of paracetamol oxycodone tablets, a series of regulations and changes have been made to domestic paracetamol oxycodone tablets packaging production enterprises, agent enterprises and business enterprises The specific contents are as follows Market supervision and administration bureaus of all regions and relevant pharmaceutical production and trading enterprises: On July 11, 2019, the State Food and drug administration, the Ministry of public security and the state health and Health Commission jointly issued the announcement on the inclusion of oxycodone containing compound preparations and other varieties in the management of psychotropic drugs (No 63, 2019) In order to do a good job in the management of the transitional period, the State Food and Drug Administration and the state health and Health Commission issued the notice on strengthening the management of paracetamol oxycodone tablets (Drug Administration of the State Food and Drug Administration [201 9] No 38, hereinafter referred to as the notice) Now, the requirements for the drug management work implemented in our city are notified as follows: 1 Paracetamol oxycodone tablet sub packaging production enterprise Sinopharm Group Industry Co., Ltd shall, in strict accordance with the requirements of the regulations on the administration of narcotic drugs and psychotropic substances, the measures for the administration of the production of narcotic drugs and psychotropic substances (for Trial Implementation), the quality management system documents shall be improved before December 1, 2019, and the storage conditions and safety management facilities meeting the regulations and actual needs shall be equipped, and the application shall be made to our bureau The second type of approval for designated production of psychotropic drugs 2、 Sinopharm holding Beijing Huahong Co., Ltd., a domestic agent of paracetamol and oxycodone tablets, shall complete the following work in strict accordance with the requirements of the regulations on the administration of narcotic drugs and psychotropic substances and the measures for the administration of the operation of narcotic drugs and psychotropic substances (for Trial Implementation): （1） From September 1, 2019, it will no longer supply goods to the enterprises without the second category of psychotropic drugs operation qualification, and the return of drugs involved shall be done according to the original channel; the import of paracetamol oxycodone tablets shall apply to the State Drug Administration for the import of psychotropic drugs in accordance with the relevant procedures （2） As of January 1, 2020, the product and imported tablets of aminophenol oxycodone must have the specified marks on their packages and instructions The modification of drug labels and instructions shall be handled in accordance with the relevant provisions of the measures for the administration of drug registration 3、 Drug distributors (1) before August 31, 2019, the drug wholesalers selling paracetamol oxycodone tablets shall register the original inventory products and report them to the drug circulation supervision and Administration Office of the Municipal Drug Administration, and the original inventory products of drug retail enterprises shall be registered and reported to the district market supervision and Administration Bureau, and shall be sold out or returned according to the original channels according to the regulations （2） From September 1, 2019, enterprises without the qualification for the second category of psychotropic drugs shall not purchase any more paracetamol oxycodone tablets Drug dealers must strictly follow the regulations on the administration of narcotic drugs and psychotropic drugs, the specifications for the administration of drug trade quality, the measures for the administration of the administration of narcotic drugs and psychotropic drugs (Trial Implementation) and the regulations of the state on the classified administration of drugs, and do a good job in the second category Safety management of psychotropic drugs The drug regulatory authorities at the two levels in the urban area should earnestly perform their duties, strengthen the supervision of the production and operation enterprises of paracetamol and oxycodone tablets, urge them to strictly implement the above provisions, ensure the medical demand, and prevent them from flowing into illegal channels Oxycodone is the opioid agonist of morphine, which is the target of drug abusers, addicts and illegal resellers Since the state vigorously supervises the production, circulation and use of narcotic drugs and psychotropic substances, it has been strengthening the production, circulation and use of such drugs to a certain extent, which has controlled the widespread use of such drugs However, in terms of drug use, the state emphasizes that the risks of drug misuse, abuse or resale should be carefully considered when prescribing But in daily clinical medication, some doctors are too cautious because of this, and the hospital has also constantly reduced the proportion of drug use restricted by departments, resulting in many patients, especially patients with advanced cancer, no medicine available, and pain can not be effectively controlled Therefore, I believe that on the one hand, the control of restrictive drugs should be strictly regulated by the state, not giving any chance to speculators, on the other hand, doctors should be encouraged to have their own medical ethics and independent thinking When the drug is used, it is necessary to use the drug, not affected by other factors, and grasp the scale, which will benefit the country and the people This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.